Cheng, Zhenshun

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 48,884

Cross-Sectional Studies

Wang, X., & Cheng, Z. (2020) · CHEST

Statistical Methods in EpidemiologyMethodologies in Health Research and Practice

Cited by 2,214

Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial

Chen, C., Zhang, Y., Huang, J., Yin, P., Cheng, Z., Wu, J., Chen, S., Zhang, Y., Chen, B., Lu, M., et al. (2020) · Frontiers in Pharmacology

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 852

Dec1 Deficiency Ameliorates Pulmonary Fibrosis Through the PI3K/AKT/GSK-3β/β-Catenin Integrated Signaling Pathway

Hu, X., Zou, M., Ni, L., Zhang, M., Zheng, W., Liu, B., & Cheng, Z. (2022) · Frontiers in Pharmacology

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisPulmonary Hypertension Research and Treatments

Cited by 21

Plasma LTBP2 as a potential biomarker in differential diagnosis of connective tissue disease-associated interstitial lung disease and idiopathic pulmonary fibrosis: a pilot study

Zou, M., Hu, X., Song, W., Gao, H., Wu, C., Zheng, W., & Cheng, Z. (2023) · Clinical and Experimental Medicine

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisSystemic Sclerosis and Related Diseases

Cited by 10